Psychotropics in pregnancy: safety and other considerations - PubMed (original) (raw)
Review
Psychotropics in pregnancy: safety and other considerations
Femi Oyebode et al. Pharmacol Ther. 2012 Jul.
Abstract
Introduction: Perinatal psychiatric disorders are important because of their adverse effects on pregnancy outcomes. The aim of this review is investigate psychotropic drugs in the management of antenatal psychiatric disorders with emphasis on the risk of harmful effects.
Method: A systematic review of published electronic literature between January 2000 and August 2011 was conducted using the following keywords: pregnancy, pregnancy complications, neonatal complications, congenital anomalies, infant/child development, antidepressants, antipsychotics, and lithium. The search was conducted for each class of psychotropic agents. Further hand searches were conducted. Anticonvulsants were excluded.
Results: Antidepressants are associated with increased risk of spontaneous abortions, stillbirths, preterm deliveries, respiratory distress, endocrine and metabolic disturbance. There is evidence of discontinuation syndrome and of increased risk of cardiac defects. Antipsychotics are associated with increased gestational weight and diabetes and with increased risk of preterm birth. The effects of antipsychotics on birth weight are inconclusive. In addition, the findings in relation to malformations are inconclusive. Lithium is associated with increased birth complications such as polyhydramnios, pre-eclampsia, respiratory distress syndrome, hypotonia, and preterm birth. Lithium has previously been associated with markedly increased risk of Ebstein's anomaly. However, recent re-evaluation of the data casts doubt on the previous estimates. There is evidence that lithium is associated with cardiac septal defects.
Conclusion: Psychotropic drugs remain an important treatment option during pregnancy to properly manage symptoms of psychiatric diseases. Clinicians need to remain aware of the potential risk of adverse effects associated with psychotropic drug treatment.
Copyright © 2012 Elsevier Inc. All rights reserved.
Similar articles
- Antidepressants, Antipsychotics, and Mood Stabilizers in Pregnancy: What Do We Know and How Should We Treat Pregnant Women with Depression.
Ornoy A, Weinstein-Fudim L, Ergaz Z. Ornoy A, et al. Birth Defects Res. 2017 Jul 17;109(12):933-956. doi: 10.1002/bdr2.1079. Birth Defects Res. 2017. PMID: 28714604 Review. - Psychotropics in pregnancy: weighing the risks.
Grover S, Avasthi A, Sharma Y. Grover S, et al. Indian J Med Res. 2006 Apr;123(4):497-512. Indian J Med Res. 2006. PMID: 16783040 Review. - Impact of prenatal exposure to psychotropic drugs on neonatal outcome in infants of mothers with serious psychiatric illnesses.
Sutter-Dallay AL, Bales M, Pambrun E, Glangeaud-Freudenthal NM, Wisner KL, Verdoux H. Sutter-Dallay AL, et al. J Clin Psychiatry. 2015 Jul;76(7):967-73. doi: 10.4088/JCP.14m09070. J Clin Psychiatry. 2015. PMID: 25844580 - Pharmacologic management of psychiatric illness during pregnancy: dilemmas and guidelines.
Altshuler LL, Cohen L, Szuba MP, Burt VK, Gitlin M, Mintz J. Altshuler LL, et al. Am J Psychiatry. 1996 May;153(5):592-606. doi: 10.1176/ajp.153.5.592. Am J Psychiatry. 1996. PMID: 8615404 - Psychotropics.
Goldaber KG. Goldaber KG. Semin Perinatol. 1997 Apr;21(2):154-9. doi: 10.1016/s0146-0005(97)80059-6. Semin Perinatol. 1997. PMID: 9201822 Review.
Cited by
- Is Antipsychotic Drug Use During Pregnancy Associated with Increased Malformation Rates and Worsening of Maternal and Infant Outcomes? A Systematic Review.
Sani G, Callovini T, Ferrara OM, Segatori D, Margoni S, Simonetti A, Lisci FM, Marano G, Fischetti A, Kotzalidis GD, Di Segni F, Fiaschè F, Janiri D, Moccia L, Manfredi G, Alcibiade A, Brisi C, Grisoni F, Stella G, Bernardi E, Brugnami A, Ciliberto M, Spera MC, Caso R, Rossi S, Boggio G, Mastroeni G, Abate F, Conte E, Quintano A, De Chiara L, Monti L, Camardese G, Rinaldi L, Koukopoulos AE, Chieffo DPR, Angeletti G, Mazza M. Sani G, et al. Curr Neuropharmacol. 2024;22(14):2402-2421. doi: 10.2174/1570159X22666240516151449. Curr Neuropharmacol. 2024. PMID: 38766824 Free PMC article. - Brain structural and functional outcomes in the offspring of women experiencing psychological distress during pregnancy.
Wu Y, De Asis-Cruz J, Limperopoulos C. Wu Y, et al. Mol Psychiatry. 2024 Jul;29(7):2223-2240. doi: 10.1038/s41380-024-02449-0. Epub 2024 Feb 28. Mol Psychiatry. 2024. PMID: 38418579 Free PMC article. Review. - Comparative Safety Analysis of Opioid Agonist Treatment in Pregnant Women with Opioid Use Disorder: A Population-Based Study.
Wang S, Meador KJ, Pawasauskas J, Lewkowitz AK, Ward KE, Brothers TN, Hartzema A, Quilliam BJ, Wen X. Wang S, et al. Drug Saf. 2023 Mar;46(3):257-271. doi: 10.1007/s40264-022-01267-z. Epub 2023 Jan 16. Drug Saf. 2023. PMID: 36642778 Free PMC article. - A Review on the Vagus Nerve and Autonomic Nervous System During Fetal Development: Searching for Critical Windows.
Cerritelli F, Frasch MG, Antonelli MC, Viglione C, Vecchi S, Chiera M, Manzotti A. Cerritelli F, et al. Front Neurosci. 2021 Sep 20;15:721605. doi: 10.3389/fnins.2021.721605. eCollection 2021. Front Neurosci. 2021. PMID: 34616274 Free PMC article. - The German Guidelines for the treatment of anxiety disorders: first revision.
Bandelow B, Werner AM, Kopp I, Rudolf S, Wiltink J, Beutel ME. Bandelow B, et al. Eur Arch Psychiatry Clin Neurosci. 2022 Jun;272(4):571-582. doi: 10.1007/s00406-021-01324-1. Epub 2021 Oct 5. Eur Arch Psychiatry Clin Neurosci. 2022. PMID: 34609587 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical